GenomAI

About GenomAI

Provides AI-driven genomic analysis that integrates genetic data, biomarkers, and family medical history to identify potential health risks and treatment options. This service enables personalized health monitoring and risk reduction by detecting and addressing the impact of genetic mutations.

```xml <problem> Individuals often lack a comprehensive understanding of their genetic predispositions to various health risks. Traditional methods of assessing these risks can be complex, costly, and may not fully integrate an individual's genetic data with their family history and other relevant health information. This can lead to delayed or inadequate preventative care and treatment. </problem> <solution> GenomAI offers an AI-driven genomic analysis platform that integrates an individual's genetic data, biomarkers, and family medical history to identify potential health risks and inform personalized treatment options. By leveraging artificial intelligence, GenomAI analyzes complex genomic data to provide users with independent and reliable insights into potential health risks and personalized solutions. The platform aims to reduce the impact of genetic mutations by integrating family history with available medical data, offering specialized genetic traceability and monitoring through partnerships with clinical labs. This enables proactive health management and early intervention based on a comprehensive understanding of an individual's genetic profile. </solution> <features> - AI-powered analysis of genomic data, biomarkers, and family medical history - Integration of genetic data with individual health information for personalized insights - Identification of potential health risks based on genetic predispositions - Partnership with clinical labs for specialized genetic traceability and monitoring - Secure platform for uploading and managing e-consent forms - User accounts with booking, order, and account management features </features> <target_audience> GenomAI primarily targets individuals and families seeking to understand their genetic predispositions to health risks and healthcare professionals looking to offer personalized medicine solutions to their patients. </target_audience> ```

What does GenomAI do?

Provides AI-driven genomic analysis that integrates genetic data, biomarkers, and family medical history to identify potential health risks and treatment options. This service enables personalized health monitoring and risk reduction by detecting and addressing the impact of genetic mutations.

Where is GenomAI located?

GenomAI is based in Danville, United States.

When was GenomAI founded?

GenomAI was founded in 2023.

Who founded GenomAI?

GenomAI was founded by Noemi Perez Paz.

  • Noemi Perez Paz - Co-Founder/CEO
Location
Danville, United States
Founded
2023
Employees
5 employees
Looking for specific startups?
Try our free semantic startup search

GenomAI

Score: 44/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Provides AI-driven genomic analysis that integrates genetic data, biomarkers, and family medical history to identify potential health risks and treatment options. This service enables personalized health monitoring and risk reduction by detecting and addressing the impact of genetic mutations.

genom-ai.com100+
Founded 2023Danville, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (5+)

Noemi Perez Paz

Co-Founder/CEO

Company Description

Problem

Individuals often lack a comprehensive understanding of their genetic predispositions to various health risks. Traditional methods of assessing these risks can be complex, costly, and may not fully integrate an individual's genetic data with their family history and other relevant health information. This can lead to delayed or inadequate preventative care and treatment.

Solution

GenomAI offers an AI-driven genomic analysis platform that integrates an individual's genetic data, biomarkers, and family medical history to identify potential health risks and inform personalized treatment options. By leveraging artificial intelligence, GenomAI analyzes complex genomic data to provide users with independent and reliable insights into potential health risks and personalized solutions. The platform aims to reduce the impact of genetic mutations by integrating family history with available medical data, offering specialized genetic traceability and monitoring through partnerships with clinical labs. This enables proactive health management and early intervention based on a comprehensive understanding of an individual's genetic profile.

Features

AI-powered analysis of genomic data, biomarkers, and family medical history

Integration of genetic data with individual health information for personalized insights

Identification of potential health risks based on genetic predispositions

Partnership with clinical labs for specialized genetic traceability and monitoring

Secure platform for uploading and managing e-consent forms

User accounts with booking, order, and account management features

Target Audience

GenomAI primarily targets individuals and families seeking to understand their genetic predispositions to health risks and healthcare professionals looking to offer personalized medicine solutions to their patients.